Giancarlo Liumbruno to Humans
This is a "connection" page, showing publications Giancarlo Liumbruno has written about Humans.
Connection Strength
0.199
-
A forecasting model to estimate the drop in blood supplies during the SARS-CoV-2 pandemic in Italy. Transfus Med. 2021 Jun; 31(3):200-205.
Score: 0.007
-
Potential mechanisms of action of convalescent plasma in COVID-19. Diagnosis (Berl). 2021 11 25; 8(4):413-420.
Score: 0.007
-
A retrospective study assessing the characteristics of COVID-19 convalescent plasma donors and donations. Transfusion. 2021 03; 61(3):830-838.
Score: 0.007
-
COVID-19-associated coagulopathy. Diagnosis (Berl). 2020 Nov 18; 7(4):357-363.
Score: 0.007
-
Regarding International Forum on Hospital Transfusion Services' Response to COVID-19. Vox Sang. 2020 11; 115(8):827.
Score: 0.007
-
The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy. Vox Sang. 2020 11; 115(8):603-605.
Score: 0.007
-
The key role of tranexamic acid in Patient Blood Management programmes. Blood Transfus. 2018 11; 16(6):471-472.
Score: 0.006
-
Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system. Blood Transfus. 2018 11; 16(6):483-489.
Score: 0.006
-
Efficacy of platelet-rich plasma as conservative treatment in orthopaedics: a systematic review and meta-analysis. Blood Transfus. 2018 11; 16(6):502-513.
Score: 0.006
-
Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey. Blood Transfus. 2018 09; 16(5):422-432.
Score: 0.006
-
A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors. Blood Transfus. 2018 09; 16(5):413-421.
Score: 0.006
-
Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis. Blood Transfus. 2018 07; 16(4):329-337.
Score: 0.006
-
The post-operative management of anaemia: more efforts are needed. Blood Transfus. 2018 07; 16(4):324-325.
Score: 0.006
-
The use of viscoelastic haemostatic assays in non-cardiac surgical settings: a systematic review and meta-analysis. Blood Transfus. 2018 05; 16(3):235-243.
Score: 0.006
-
The importance of ABO blood group in pharmacokinetic studies in haemophilia A. Haemophilia. 2018 05; 24(3):e122-e123.
Score: 0.006
-
Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials. Blood Transfus. 2018 01; 16(1):36-43.
Score: 0.006
-
Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia. Semin Thromb Hemost. 2018 Sep; 44(6):595-603.
Score: 0.006
-
Is there a standard-of-care for transfusion therapy in thalassemia? Curr Opin Hematol. 2017 Nov; 24(6):558-564.
Score: 0.006
-
Ten years since the last Chikungunya virus outbreak in Italy: history repeats itself. Blood Transfus. 2017 10; 15(6):489-490.
Score: 0.006
-
Red blood cell transfusion policy: a critical literature review. Blood Transfus. 2017 Jul; 15(4):307-317.
Score: 0.006
-
The use of fibrinogen concentrate for the management of trauma-related bleeding: a systematic review and meta-analysis. Blood Transfus. 2017 Jul; 15(4):318-324.
Score: 0.006
-
The Italian Regulatory Guidelines for the implementation of Patient Blood Management. Blood Transfus. 2017 07; 15(4):325-328.
Score: 0.006
-
Acquired hemophilia A: a review of recent data and new therapeutic options. Hematology. 2017 Oct; 22(9):514-520.
Score: 0.006
-
A cost analysis of public cord blood banks belonging to the Italian Cord Blood Network. Blood Transfus. 2018 05; 16(3):313-320.
Score: 0.006
-
The Role of ABO Blood Type in Thrombosis Scoring Systems. Semin Thromb Hemost. 2017 Jul; 43(5):525-529.
Score: 0.006
-
Red blood cell storage and clinical outcomes: new insights. Blood Transfus. 2017 03; 15(2):101-103.
Score: 0.006
-
Peri-operative anaemia management in major orthopaedic surgery: the need to find a pathway. Blood Transfus. 2017 07; 15(4):289-291.
Score: 0.006
-
The human pegivirus: A new name for an "ancient" virus. Can transfusion medicine come up with something new? Acta Virol. 2017; 61(4):401-412.
Score: 0.006
-
"Efficacy and Safety of Fibrinogen Concentrate in Surgical Patients: A Meta-analysis of Randomized Controlled Trials". J Cardiothorac Vasc Anesth. 2017 04; 31(2):e33-e35.
Score: 0.006
-
Fibrinogen concentrate in surgery. Blood Transfus. 2017 05; 15(3):215-217.
Score: 0.005
-
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma. Transfus Clin Biol. 2022 02; 29(1):101-102.
Score: 0.002
-
Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors. Transfus Apher Sci. 2021 12; 60(6):103216.
Score: 0.002
-
COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol. 2021 Aug; 107(2):173-180.
Score: 0.002
-
Patient blood management during the COVID-19 pandemic: a narrative review. Anaesthesia. 2020 08; 75(8):1105-1113.
Score: 0.002
-
Factors affecting the quality, safety and marketing approval of clotting factor concentrates for haemophilia. Blood Transfus. 2018 11; 16(6):525-534.
Score: 0.002
-
An early start of West Nile virus seasonal transmission: the added value of One Heath surveillance in detecting early circulation and triggering timely response in Italy, June to July 2018. Euro Surveill. 2018 08; 23(32).
Score: 0.002
-
An international consensus statement on the management of postoperative anaemia after major surgical procedures. Anaesthesia. 2018 Nov; 73(11):1418-1431.
Score: 0.002
-
Current misconceptions in diagnosis and management of iron deficiency. Blood Transfus. 2017 Sep; 15(5):422-437.
Score: 0.001